Role of Oxidative Stress in the Pathophysiological Mechanism of Erectile Dysfunction
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Erectile dysfunction (ED) is defined as the inability to achieve or maintain erections sufficient for satisfactory sexual intercourse (NIH Consensus Conference, 1993). It is estimated that the prevalence of ED will double in the next 25 years. Normal erectile function depends on a precise balance between psychological, hormonal, neurological, vascular, and cavernosal factors. Therefore, an alteration in any one or combination of these factors may lead to ED. For many years, the complex interaction between the origin of impulse and the normal erectile response was not clearly understood. It was not until the early 1990s when the roles of central and peripheral phenomena in the normal erectile response was proposed. The identification of the roles of various mediators, as well as their interactions, in normal erectile function is a major development in the study of ED. Production of nitric oxide (NO) plays a central physiological role in erections. The endothelium is the primary source of NO (Burnett, 1997). The pathophysiological mechanism of endothelial dysfunction is multifactorial, and the major outcome is impaired release of NO, which leads to ED. Although NO-mediated relaxation plays a central role in erections, other mediators, such as prostaglandins, endothelin, and bradykinins, are also important in maintaining penile tone. Researchers have made great strides in the past two decades in identifying the pathophysiological mechanism in ED. However, the precise pathophysiological mechanism is still unclear. There is a growing interest among researchers regarding the role of oxidative stress in the pathophysiological mechanism of ED. Oxidative stress occurs when there is an imbalance between pro-oxidants and the ability of the antioxidants to scavenge excess reactive oxygen species. The role of oxidative stress and reactive oxygen species has been extensively evaluated in the pathophysiological mechanisms of male and female infertility. However, its role in ED has not been investigated comprehensively. Initial reports from both in vitro and in vivo studies have shown a significant association between the production of reactive oxygen species and erectile dysfunction, especially in diabetic animal models. In this article, we discuss the role of oxidative stress in the pathophysiological mechanism of ED and the therapeutic interventions and preventive strategies that may be beneficial in restoring endothelial function and normal erectile function. ED is a highly prevalent and often underreported condition. The prevalence of ED varies in different countries (NIH Consensus Conference, 1993). Approximately 20–30 million men in the United States and approximately 0.5 million men in the UK have ED of varying severity (NIH Consensus Conference, 1993). According to the Massachusetts Male Aging Study, 52% of men in the United States between the ages of 40 and 70 years have ED (Feldman et al, 1994). The incidence is approximately 32% in the United Kingdom (Spector and Boyle, 1986), 26% in Japan (Melman and Gingell, 1999), and 19% in Denmark (Solstad and Davidsen, 1993). However, some men are unwilling to report the problem, because of their social and cultural backgrounds. This makes it difficult to determine the precise prevalence of ED. Furthermore, the paucity of epidemiological studies reported in the literature from developing and underdeveloped countries further compound this problem. Additional studies are needed to estimate the worldwide prevalence of ED. The available literature suggests that ED is a mounting problem. The etiology of ED is multifactorial and can be classified as organic, neurogenic, and mixed. In organic ED, vasculogenic causes are common. The major risk factors implicated in the pathophysiological mechanism of organic ED are diabetes mellitus, hypercholesterolemia, smoking, and chronic medical illness. All of these factors increase the risk of atherosclerosis, which is the predominant predisposing cause of vasculogenic ED. Kaiser et al (1988) reported that atherosclerotic disease was the cause of ED in approximately 40% of men more than 50 years old (Kaiser et al, 1988). Atherosclerosis, along with other risk factors, is associated with endothelial dysfunction, which plays a crucial role in vasculogenic ED (Zeiher et al, 1993). The physiological mechanism of erection is a complex neurovascular phenomenon that depends on neural, vascular, hormonal, and psychological factors. Integrated function of these factors is essential for production of a normal erectile response. Recent advances in the understanding of functional anatomy and of neurovascular interactions have improved our understanding of the pathophysiological mechanism of ED. NO has been implicated in diverse physiological functions, including regulation of neural transmission in vascular tissue and immune system function (Moncada et al, 1991). The vasodilator effects in most vascular beds are mediated by endothelial derived relaxin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · cited 3×
“NO has been established as an EDRF (Palmer et al, 1987) and shown to play central role in the physiological mechanism of penile erection by initiating smooth-muscle relaxation (Burnett, 1997).”
BackgroundOxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958 · cited 1×
“Oxidative damage to the vasculature due to oxidative damage caused by superoxide anion plays a role in the natural aging process (Ames et al, 1993; Ferrara et al, 1995).”
BackgroundNitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119 · cited 1×
“Although the development of ED is multifactorial in nature, it is typically associated with vascular diseases and risk factors, such as artherosclerosis, hypertension, diabetes mellitus, and cigarette smoking (Feldman et al, 1994; Laumann et al, 1999; Bivalacqua et al, 2000).”
BackgroundImpotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074 · cited 4×
“According to the Massachusetts Male Aging Study, 52% of men in the United States between the ages of 40 and 70 years have ED (Feldman et al, 1994).”
BackgroundMethodInfluentialNitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110 · cited 1×
“Some of these have the potential to treat a range of inflammatory and noninflammatory conditions in which iNOS has been implicated (Alderton et al, 2001).”
BackgroundHypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070 · cited 1×
“Deficiency of endothelial NO has been implicated in some forms of hypertension (Huang et al, 1995; Baylis and Vallance, 1996; Soma et al, 1999).”
BackgroundThe elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179 · cited 2×
“…of reactive oxygen species (Tepel et al, 2000), elevated levels of plasma lipid oxidation products, increased levels of F2-isoprostanes, increased myeloperoxidase catalyzed oxidation, and reduced levels of antioxidant enzymes have been reported in chronic renal failure (Himmelfarb et al, 2002).”
Background(1992) · doi:10.1126/science.1378650 · Cited by 1,163
Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260203 · Cited by 1,006
Age-Related Reduction of NO Availability and Oxidative Stress in Humans
Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Bernini, G., Magagna, A., & Salvetti, A. (2001) · Hypertension · doi:10.1161/01.hyp.38.2.274 · Cited by 664
(1991) · doi:10.1172/jci115266 · Cited by 429 · cited 2×
“…tract, NO is a neurotransmitter involved in nonadregenic, noncholinergic neurotransmission (Sanez de Tezada et al, 1989; Ignarro et al, 1990; Kim et al, 1991; Knispel et al, 1991; Andersson et al, 1992; Burnett et al, 1992; Rajfer et al, 1992; Burnett et al, 1993, 1995) and is a vasodilator…”
BackgroundRole of Angiotensin and Oxidative Stress in Essential Hypertension
Romero, J. C., & Reckelhoff, J. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.943 · Cited by 358 · cited 1×
“These effects could be mediated by a reduction in the concentration of NO, along with the formation of F2isoprostanes and endothelin (Romero and Reckelhoff, 1999; Reckelhoff and Romero, 2003).”
BackgroundTHE EPIDEMIOLOGY AND PATHOPHYSIOLOGY OF ERECTILE DYSFUNCTION
MELMAN, A., & GINGELL, J. C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62045-7 · Cited by 308
(1994) · doi:10.1093/oxfordjournals.aje.a117189 · Cited by 193
Keegan, A., Cotter, M. A., & Cameron, N. E. (1999) · Diabetologia · doi:10.1007/s001250051161 · Cited by 114 · cited 1×
“The role of antioxidants, such as a-lipoic acid (ALA) and linolenic acid, in the prevention of cavernosal dysfunction was examined in vivo in a diabetic rat model (Keegan et al, 1999).”
Background
Cited by
The effect of obesity on sperm disorders and male infertility
Du Plessis, S. S., Cabler, S., McAlister, D. A., Sabanegh, E., & Agarwal, A. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.6 · Cited by 422
Self-citationThe Metabolic Syndrome and Male Infertility
Kasturi, S. S., Tannir, J., & Brannigan, R. E. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.003731 · Cited by 308
Paulis, G., Romano, G., Paulis, L., & Barletta, D. (2017) · Advances in Urology · doi:10.1155/2017/4653512 · Cited by 44
“Oxidative stress, furthermore, is an important factor in the possible onset of erectile dysfunction in PD, as hyperproduction of superoxide anion and peroxynitrite reduces nitric oxide concentration available for cavernosal muscle relaxation, resulting in long-term endothelial damage; superoxide anion is also reported…”
BackgroundPaulis, G., De Giorgio, G., & Paulis, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415969 · Cited by 21
“The iNOS enzyme is therefore locally produced in excess (100 to 1000 times more concentrated than normal constitutive NOS), leading to a chemical reaction and the production of high concentrations of nitric oxide radical (NO•-); i-NOS also bolsters the local synthesis of collagen [43,59].”
Background
Metadata
- Authors
- Agarwal, A., Nandipati, K. C., Sharma, R. K., Zippe, C. D., & Raina, R.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2006-05-06
- Volume
- 27
- Issue
- 3
- Pages
- 335-347
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W2103760597
- Cited by
- 225
- References
- 17
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.